featured
Adverse Cardiovascular Outcomes Associated With Coprescription of PDE5 and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study
Ann. Intern. Med 2022 Apr 19;[EPub Ahead of Print], A Holt, P Blanche, AKG Jensen, N Nouhravesh, D Rajan, MH Jensen, M El-Sheikh, AM Schjerning, M Schou, G Gislason, C Torp-Pedersen, P McGettigan, M LambertsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.